Hartmut STROBEL

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Acylated indanyl amines and their use as pharmaceuticals

Imidazo[1,2-a]pyridines and their use as pharmaceuticals

Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents

Heteroaryl-substituted carboxamides and their use as pharmaceuticals

Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals

Heteroarylacrylamides and their use as pharmaceuticals

Imidazo[2,1-b]thiazoles and their use as pharmaceuticals

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors

Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors

Acylated indanyl amines and their use as pharmaceuticals

Acylated arylcycloalkylamines and their use as pharmaceuticals

Acylated indanyl amines and their use as pharmaceuticals

Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them

Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals

Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals

Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them

Method for screening for activators of soluble guanylate cyclase having oxidized heme iron

Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents

Pyrazole derivatives, their preparation and their use in pharmaceuticals

Luminescent method of detecting soluble guanylate cyclase

Pyrazole derivatives, their preparation and their use in pharmaceuticals

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators

4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical

Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same